HLB 무료 바카라 게임 signs exclusive supply agreement with Bioserve in India, launching full-scale 무료 바카라 게임tide raw material exports

[by Lee, Young Sung] HLB 무료 바카라 게임, a company specializing in 무료 바카라 게임tide-based technologies, announced on August 5 the signing of an exclusive 무료 바카라 게임tide material supply agreement with the Indian biotechnology firm Bioserve Biotechnologies. This agreement is expected to facilitate the global expansion of HLB 무료 바카라 게임’s material exports.

Under the terms of the agreement, Bioserve will import high-quality 무료 바카라 게임tide raw materials produced by HLB 무료 바카라 게임 and serve as the exclusive distributor for research use across India. HLB 무료 바카라 게임 emphasized the significance of this partnership, noting that it represents a meaningful step in expanding the global reach of HLB 무료 바카라 게임’s 무료 바카라 게임tide production technology, the only company in Korea to have obtained GMP certification.

Bioserve, a subsidiary of the Japanese regenerative medicine firm Reprocell, is widely recognized in India for its technological expertise, particularly in the fields of DNA synthesis and genetic analysis services. Its client base includes major Indian universities, public research institutes, and biotechnology companies.

Since its incorporation into the HLB Group in March, HLB 무료 바카라 게임 has actively pursued international market expansion. In May of this year, the company’s enuresis treatment raw material, ‘desmopressin,’ received approval as a finished pharmaceutical product. Furthermore, HLB 무료 바카라 게임 is expected to undergo a U.S. FDA inspection next year in preparation for the launch of its infertility treatment raw material, ‘Ganirelix,’ in the U.S. market.

"This agreement with Bioserve represents a strategic step toward expanding our sales in the highly promising Indian market,” said Shim Kyoung-jae, CEO of HLB 무료 바카라 게임. “We expect strong synergy in the Indian biotechnology sector through collaboration with Bioserve, which possesses an extensive market network."

On the other hand, the Indian 무료 바카라 게임tide therapeutics market is projected to reach USD 985 million (KRW 1.36 trillion) by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 12.6%, reaching an estimated USD 2.26 billion by 2030.